These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 1589400)
1. Bisacylphosphonates inhibit hydroxyapatite formation and dissolution in vitro and dystrophic calcification in vivo. Golomb G; Schlossman A; Saadeh H; Levi M; Van Gelder JM; Breuer E Pharm Res; 1992 Jan; 9(1):143-8. PubMed ID: 1589400 [TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo anticalcification effects of novel bishydroxyiminophosphonates. Golomb G; Schlossman A; Eitan Y; Saadeh H; Van Gelder JM; Breuer E J Pharm Sci; 1992 Oct; 81(10):1004-7. PubMed ID: 1432609 [TBL] [Abstract][Full Text] [Related]
3. Anticalcification and antiresorption effects of bisacylphosphonates. Van Gelder JM; Breuer E; Ornoy A; Schlossman A; Patlas N; Golomb G Bone; 1995 May; 16(5):511-20. PubMed ID: 7654466 [TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo effects of tetrakisphosphonates on bone resorption, tumor osteolysis, ectopic calcification, and macrophages. Van Gelder JM; Breuer E; Schlossman A; Ornoy A; Mönkkönen J; Similä J; Klenner T; Stadler H; Krempien B; Patlas N; Golomb G J Pharm Sci; 1997 Mar; 86(3):283-9. PubMed ID: 9050794 [TBL] [Abstract][Full Text] [Related]
5. Controlled-release drug delivery of diphosphonates to inhibit bioprosthetic heart valve calcification: release rate modulation with silicone matrices via drug solubility and membrane coating. Golomb G; Dixon M; Smith MS; Schoen FJ; Levy RJ J Pharm Sci; 1987 Apr; 76(4):271-6. PubMed ID: 3110404 [TBL] [Abstract][Full Text] [Related]
6. Experimental basis for the use of bisphosphonates in Paget's disease of bone. Fleisch H Clin Orthop Relat Res; 1987 Apr; (217):72-8. PubMed ID: 3549097 [TBL] [Abstract][Full Text] [Related]
7. Controlled release of diphosphonates from synthetic polymers to inhibit calcification. Golomb G J Biomater Appl; 1987 Oct; 2(2):266-89. PubMed ID: 3144594 [TBL] [Abstract][Full Text] [Related]
8. Prevention of leaflet calcification of bioprosthetic heart valves with diphosphonate injection therapy. Experimental studies of optimal dosages and therapeutic durations. Levy RJ; Schoen FJ; Lund SA; Smith MS J Thorac Cardiovasc Surg; 1987 Oct; 94(4):551-7. PubMed ID: 3116348 [TBL] [Abstract][Full Text] [Related]
9. Bisphosphonates and tetracycline: experimental models for their evaluation in calcium-related disorders. Cohen H; Solomon V; Alferiev IS; Breuer E; Ornoy A; Patlas N; Eidelman N; Hägele G; Golomb G Pharm Res; 1998 Apr; 15(4):606-13. PubMed ID: 9587958 [TBL] [Abstract][Full Text] [Related]
10. Effects of metallic ions and diphosphonates on inhibition of pericardial bioprosthetic tissue calcification and associated alkaline phosphatase activity. Hirsch D; Schoen FJ; Levy RJ Biomaterials; 1993 Apr; 14(5):371-7. PubMed ID: 8507781 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of ectopic calcification of glutaraldehyde crosslinked collagen and collagenous tissues by a covalently bound diphosphonate (APD). Nimni ME; Ertl D; Villanueva J; Nimni BS Am J Cardiovasc Pathol; 1990; 3(3):237-45. PubMed ID: 2095830 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of the in vivo inhibition of calcification of bioprosthetic porcine aortic valve cusps and aortic wall with triglycidylamine/mercapto bisphosphonate. Rapoport HS; Connolly JM; Fulmer J; Dai N; Murti BH; Gorman RC; Gorman JH; Alferiev I; Levy RJ Biomaterials; 2007 Feb; 28(4):690-9. PubMed ID: 17027944 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of bioprosthetic heart valve calcification with aminodiphosphonate covalently bound to residual aldehyde groups. Webb CL; Benedict JJ; Schoen FJ; Linden JA; Levy RJ Ann Thorac Surg; 1988 Sep; 46(3):309-16. PubMed ID: 3137904 [TBL] [Abstract][Full Text] [Related]
14. Bisphosphonates: a new class of drugs in diseases of bone and calcium metabolism. Fleisch H Recent Results Cancer Res; 1989; 116():1-28. PubMed ID: 2669065 [TBL] [Abstract][Full Text] [Related]
15. Inhibition by diphosphonate compounds of calcification of porcine bioprosthetic heart valve cusps implanted subcutaneously in rats. Levy RJ; Hawley MA; Schoen FJ; Lund SA; Liu PY Circulation; 1985 Feb; 71(2):349-56. PubMed ID: 3917378 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of cusp and aortic wall calcification in ethanol- and aluminum-treated bioprosthetic heart valves in sheep: background, mechanisms, and synergism. Levy RJ; Vyavahare N; Ogle M; Ashworth P; Bianco R; Schoen FJ J Heart Valve Dis; 2003 Mar; 12(2):209-16; discussion 216. PubMed ID: 12701794 [TBL] [Abstract][Full Text] [Related]
17. Morphogenesis of calcification in porcine bioprosthesis: insight from high resolution electron microscopic investigation at molecular and atomic resolution. Lee YS J Electron Microsc (Tokyo); 1993 Jun; 42(3):156-65. PubMed ID: 8397272 [TBL] [Abstract][Full Text] [Related]
18. The effects of anticalcification treatments on bioprosthetic heart valves implanted in sheep. Jones M; Eidbo EE; Hilbert SL; Ferrans VJ; Clark RE ASAIO Trans; 1988; 34(4):1027-30. PubMed ID: 3219249 [TBL] [Abstract][Full Text] [Related]